EI-011

N/A

Report date: 2023/03/08 11:45:35

Base Information

Drug NameEI-011

Drug Alias NameEI-011

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionAnti-Programmed death-ligand 1Interleukin 10 receptor agonists

TargetsProgrammed death-ligand 1Interleukin 10 receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesElixiron Immunotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesElixiron Immunotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A